In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-1464
Full Text
Open PDFAbstract
Available in full text
Date
January 17, 2017
Authors
Publisher
American Association for Cancer Research (AACR)